BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6696387)

  • 1. Epoxide hydrolase: a marker for experimental hepatocarcinogenesis.
    Griffin MJ; Gengozian N
    Ann Clin Lab Sci; 1984; 14(1):27-31. PubMed ID: 6696387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating epoxide hydrolase immunodeterminants in rats bearing hyperplastic nodules induced by 2-acetylaminofluorene.
    Palakodety RB; Griffin MJ; Broyles RH
    Cancer Lett; 1988 Jan; 38(3):347-53. PubMed ID: 2450639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantiation of epoxide hydrolase released from hyperplastic nodule and hepatoma microsomes.
    Griffin MJ; Noda K
    Cancer Res; 1980 Aug; 40(8 Pt 1):2768-73. PubMed ID: 7388827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of microsomal, xenobiotic epoxide hydrolase messenger RNA in persistent hepatocyte nodules and hepatomas induced by chemical carcinogens.
    Ding VD; Cameron R; Pickett CB
    Cancer Res; 1990 Jan; 50(2):256-60. PubMed ID: 2295064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of epoxide hydrase as the preneoplastic antigen in rat liver hyperplastic nodules.
    Levin W; Lu AY; Thomas PE; Ryan D; Kizer DE; Griffin MJ
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3240-3. PubMed ID: 210455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury.
    Moody DE; Loury DN; Hammock BD; Ruebner BH; Cullen JM; Hillman JH; Hillman DW; Rao MS; London WT; Hann HW
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):395-403. PubMed ID: 1339049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of rat liver microsomal epoxide hydrolase as a marker of hepatocarcinogenesis.
    Kizer DE; Clouse JA; Ringer DP; Hanson-Painton O; Vaz AD; Palakodety RB; Griffin MJ
    Biochem Pharmacol; 1985 May; 34(10):1795-800. PubMed ID: 4004895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of epoxide hydrolase during experimental liver carcinogenesis.
    Enomoto K; Ying TS; Griffin MJ; Farber E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3281-7. PubMed ID: 7020925
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of monoclonal antibodies to preneoplastic liver cell populations induced by chemical carcinogens in rats and to transplantable Morris hepatomas.
    Dunsford HA; Sell S
    Cancer Res; 1989 Sep; 49(17):4887-93. PubMed ID: 2474376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of epoxide hydrolase in cultured rat hepatocytes and hepatoma cell lines.
    Razzouk C; McManus ME; Hayashi S; Schwartz D; Thorgeirsson SS
    Biochem Pharmacol; 1985 May; 34(9):1537-42. PubMed ID: 3994764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative in vitro stability of ornithine decarboxylase from liver preneoplastic nodules and hepatomas.
    Gravela E; Zuretti MF; Papino F; Sartorio L
    Cancer Res; 1983 May; 43(5):2298-300. PubMed ID: 6831453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and quantitation of preneoplastic antigen from hyperplastic nodules and normal liver.
    Griffin MJ; Kizer DE
    Cancer Res; 1978 Apr; 38(4):1136-41. PubMed ID: 346204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal cholesterol epoxide hydrolase activity in 2-acetylaminofluorene-induced rat liver hyperplastic nodules.
    Palakodety RB; Vaz AD; Griffin MJ
    Biochem Pharmacol; 1987 Jul; 36(14):2424-7. PubMed ID: 3606651
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of rat microsomal epoxide hydrolase gene during liver chemical carcinogenesis.
    Kondo S; Carr BI; Takagi K; Huang TH; Chou YM; Yokoyama K; Itakura K
    Cancer Res; 1990 Oct; 50(19):6222-8. PubMed ID: 2400988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of albumin as genotypic marker of preneoplastic analbuminemic rat hepatocytes transplanted within albumin-positive liver.
    Yokota K; Ogawa K; Mori M; Nagase S
    Cancer Res; 1988 Jan; 48(2):387-92. PubMed ID: 2891435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of immunospecific methods for quantitative estimation of microsomal epoxide hydrolase].
    D'iakov VL; Dubovskoĭ AV; Klimova OA; Sukhanov VA
    Vopr Med Khim; 1989; 35(1):47-52. PubMed ID: 2500777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis.
    Kitahara A; Satoh K; Nishimura K; Ishikawa T; Ruike K; Sato K; Tsuda H; Ito N
    Cancer Res; 1984 Jun; 44(6):2698-703. PubMed ID: 6722802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas.
    Bock KW; Lilienblum W; Pfeil H; Eriksson LC
    Cancer Res; 1982 Sep; 42(9):3747-52. PubMed ID: 6179609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver.
    Buchmann A; Kuhlmann W; Schwarz M; Kunz W; Wolf CR; Moll E; Friedberg T; Oesch F
    Carcinogenesis; 1985 Apr; 6(4):513-21. PubMed ID: 3921270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal epoxide hydrolase. Properties, regulation and function.
    Seidegård J; DePierre JW
    Biochim Biophys Acta; 1983 Dec; 695(3-4):251-70. PubMed ID: 6418203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.